Singapore- and India-based health-tech company Qritive raised $12 million in a funding round led by Jungle Ventures to scale its AI-driven pathology diagnostics solutions globally. The startup develops computer-vision tools for cancer detection and clinical workflow automation. Capital will finance regulatory approvals, R&D enhancements, and expansion into the US and Middle East. Qritive plans to partner with major laboratories to deploy its platform at scale. Investors said the round underscores growing confidence in AI healthcare applications that reduce diagnostic backlogs and improve clinical accuracy.